IE37237L - Pyrroleacetic acid derivatives - Google Patents

Pyrroleacetic acid derivatives

Info

Publication number
IE37237L
IE37237L IE721781A IE178172A IE37237L IE 37237 L IE37237 L IE 37237L IE 721781 A IE721781 A IE 721781A IE 178172 A IE178172 A IE 178172A IE 37237 L IE37237 L IE 37237L
Authority
IE
Ireland
Prior art keywords
acid derivatives
pyrroleacetic acid
pyrroleacetic
derivatives
acid
Prior art date
Application number
IE721781A
Other versions
IE37237B1 (en
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE777207A external-priority patent/BE777207A/en
Priority claimed from BE785274A external-priority patent/BE785274R/en
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of IE37237L publication Critical patent/IE37237L/en
Publication of IE37237B1 publication Critical patent/IE37237B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
IE1781/72A 1971-12-23 1972-12-21 Derivatives of pyrroleacetic acids salts thereof and their process of preparation IE37237B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE777207A BE777207A (en) 1971-12-23 1971-12-23 3-pyrroleacetic acids - analgesics, antipyretics antiinflammatories prepd by hydrolysis of the corresp acid deriv
BE785274A BE785274R (en) 1972-06-22 1972-06-22 Pyrrole-3-acetic acids - useful as antiinflammatory analgesic and anti pyretic agents

Publications (2)

Publication Number Publication Date
IE37237L true IE37237L (en) 1973-06-23
IE37237B1 IE37237B1 (en) 1977-06-08

Family

ID=25656964

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1781/72A IE37237B1 (en) 1971-12-23 1972-12-21 Derivatives of pyrroleacetic acids salts thereof and their process of preparation

Country Status (19)

Country Link
JP (1) JPS5318507B2 (en)
AR (1) AR208494A1 (en)
AT (1) AT323727B (en)
AU (1) AU467602B2 (en)
CA (1) CA991193A (en)
CH (1) CH563364A5 (en)
DD (1) DD104976A5 (en)
DE (1) DE2261965A1 (en)
DK (1) DK134599B (en)
ES (1) ES409944A1 (en)
FR (1) FR2164857B1 (en)
GB (1) GB1406330A (en)
HU (1) HU165900B (en)
IE (1) IE37237B1 (en)
IL (1) IL41146A (en)
NL (1) NL7217521A (en)
OA (1) OA04523A (en)
PL (1) PL89071B1 (en)
SE (1) SE388853B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2645234A1 (en) * 1976-10-07 1978-04-20 Basf Ag 2,5-DIALKOXY-3-AMINO-METHYLTETRAHYDROFURANS AND THE METHOD FOR THEIR PRODUCTION
US4248784A (en) * 1977-02-25 1981-02-03 Sterling Drug Inc. Pyrrole-3-acetamides
DE3026402A1 (en) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Non-steroidal antiinflammatory agents - for treatment of micro:vascular disease, e.g. diabetic retinopathy or diabetic nephropathy
US4851427A (en) * 1985-10-25 1989-07-25 Sandoz Pharm. Corp. Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use
US4973704A (en) * 1985-10-25 1990-11-27 Sandoz Pharm. Corp. Pyrrolyl intermediates in the synthesis of pyrrole analogs of mevalonolactone and derivatives thereof
EP0221025A1 (en) * 1985-10-25 1987-05-06 Sandoz Ag Heterocyclic analogs of mevalonolactone and derivatives thereof, processes for their production and their use as pharmaceuticals
DE3915450A1 (en) * 1989-05-11 1990-11-15 Gerd Prof Dr Dannhardt SUBSTITUTED PYRROL COMPOUNDS AND THEIR USE IN PHARMACY
US5260451A (en) * 1989-05-11 1993-11-09 Merckle Gmbh Substituted pyrrole compounds and use thereof in pharmaceutical compositions
DK0946507T3 (en) * 1996-12-10 2004-01-26 Searle & Co Substituted pyrrolyl compounds for the treatment of inflammation
US7906551B2 (en) 2006-08-03 2011-03-15 Rottapharm S.P.A. 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective COX-2 inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1228301A (en) * 1968-04-16 1971-04-15

Also Published As

Publication number Publication date
AU5033872A (en) 1974-06-20
IE37237B1 (en) 1977-06-08
CH563364A5 (en) 1975-06-30
HU165900B (en) 1974-12-28
GB1406330A (en) 1975-09-17
AT323727B (en) 1975-07-25
JPS4868562A (en) 1973-09-18
DE2261965A1 (en) 1973-06-28
OA04523A (en) 1980-03-30
SE388853B (en) 1976-10-18
NL7217521A (en) 1973-06-26
FR2164857B1 (en) 1976-03-05
AR208494A1 (en) 1977-02-15
AU467602B2 (en) 1974-06-20
PL89071B1 (en) 1976-10-30
CA991193A (en) 1976-06-15
JPS5318507B2 (en) 1978-06-15
FR2164857A1 (en) 1973-08-03
DK134599B (en) 1976-12-06
DD104976A5 (en) 1974-04-05
IL41146A (en) 1977-03-31
DK134599C (en) 1977-05-09
ES409944A1 (en) 1976-03-16

Similar Documents

Publication Publication Date Title
IL40521A (en) 1-heterocyclyl-3-indolealkanoic acid derivatives
IL38605A0 (en) P-methane-carboxamide derivatives
IE36079L (en) Benzazine derivatives
CY980A (en) 3-substituted-morphinan derivatives
IL39376A0 (en) Prostanoic acid derivatives
HK22577A (en) Oxidiazolone derivatives
AU4847172A (en) Cycloalkylaminoarylcarboxylic acid derivatives
ZA728402B (en) Citric acid derivatives
AU4936072A (en) Citric acid derivatives
CA957371A (en) Carbamoyl-triiodophenoxy-ethoxy-propionic acid derivatives
IE37237L (en) Pyrroleacetic acid derivatives
IL39880A0 (en) 2-nitro-5-imidazolaldehyde derivatives
ZA728403B (en) Citric acid derivatives
IL38936A0 (en) Lumilysergol derivatives
ZA723158B (en) 2-p-nitro-or p-chlorobenzamidoaceto-hydroxamic acid
CA967161A (en) Piperidine-acetic acid derivatives
PH9500A (en) 6-amino-penicillanic acid derivatives
HK29777A (en) Triazolyl-ethenyl-phenylene derivatives
GB1408201A (en) Adenosine-5-carboxylate derivatives
PH9332A (en) 2-chloroethanephosphonic acid derivatives
GB1405794A (en) Alpha-thioacetic acid derivatives
IE37196L (en) Diphenylpyrazolium derivatives
GB1402325A (en) Dibenzoxirenoazepine derivatives
IL39834A0 (en) Beta-phenyl-beta-fluorethane derivatives
ZA721364B (en) Penicilloic acid derivatives